Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Cannabis
13 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Dietary Supplements
An Economic Update on Natural Health and Cannabis Products during COVID-19
PAP-Q3-20-CL-026
In Conversation
In Conversation: Pressure BioSciences — Putting Pressure on Quality Research, Drug Development, and Cannabis (CBD) Products
PAP-Q1-20-CL-023
Cannabis
Providing Self Care Experiences With Functional Cannabis
PAP-Q1-20-CL-038
Cannabinoids
Leveraging Biosynthetic Expertise to Access a Wide Portfolio of Cannabinoids
PAP-Q3-19-CL-031
Market Prediction
Cannabis Market Worth $39.4 Billion by 2023 - Exclusive Report by MarketsandMarkets™
PR-M11-18-NI-099
Cannabis
Beleave Announces Seven-for-One Share Split
PR-M11-18-NI-027
Cannabis
The Medical Cannabis Market is Set to Expand as North American Continues to Grow
PR-M11-18-NI-025
Cannabis
Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales
PR-M11-18-NI-001
Cannabis
The Wave of Cannabis Legalization is Impending Abroad
PR-M07-18-NI-019
Cannabis
Cannabics Pharmaceuticals Enters a Memorandum of Understanding With Clinical-Stage Biopharmaceutical Company Focused on the Treatment of Ophthalmic Disorders
PR-M07-18-NI-004
FDA Approval
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy
PR-M06-18-NI-095
Cannabis
International Cannabis Legalization to Spur Global Medical and Recreational Sales
PR-M06-18-NI-049
Cannabis
Recent Developments in the Medical and Legal Cannabis Industry
PR-M06-18-NI-034
